The Bardo Foundation recently attended the White House Cancer Moonshot event, which was dedicated to discussing the progress and plans towards reducing the death rate from cancer by at least 50% in the next 25 years and ending cancer as we know it today. The focus of the event was on pediatric cancer and childhood cancer.
The event was attended by doctors, researchers, patients, and parents who were all focused on finding better solutions for pediatric cancer. The Bardo Foundation was represented by its CoFounder, Bjarne Eggesbo, who advocated for better treatment for Osteosarcoma.
The event was hosted by President Joe Biden and First Lady Dr. Jill Biden, and was also attended by Dr. Catharine Young. The Bardo Foundation is grateful for the leadership of President Biden and his team for including childhood cancer in this important initiative.
The Bardo Foundation is proud to be a part of this movement to end childhood cancer. The White House Cancer Moonshot event was a major step towards ending cancer as we know it today, and the Bardo Foundation is honored to have been a part of it. We will continue to work towards our goal of ending childhood cancer and finding better solutions for pediatric cancer patients.
The Bardo Foundation is proud to announce the success of this year's annual charity golf tournament, The Bardo Open. The event, held to raise funds for research into a cure for Osteosarcoma, was a resounding success, with nearly $80,000 raised for this important cause.
This year's tournament was sold out, with golfers from across the region coming together to show their support for the fight against Osteosarcoma. The event was a fun-filled day on the greens, followed by a fantastic dinner, where participants had the opportunity to mix and mingle with one another and hear more about the research being supported by the Bardo Foundation.
The funds raised at this year's tournament will be used to support the research of Professor Nance DeMore of the Medical University of South Carolina. Professor DeMore's work is at the forefront of efforts to find a cure for Osteosarcoma, and we are proud to support her in this important work.
The Bardo Foundation would like to extend our sincere thanks to all of the very generous sponsors who made this year's event possible. Your support has enabled us to bring us one step closer to finding a cure for Osteosarcoma and making a real difference in the lives of those affected by this devastating disease.
In conclusion, we would like to thank everyone who participated in this year's Bardo Open. Your generosity and support make it possible for us to continue our mission of finding a cure for Osteosarcoma. We look forward to seeing you all again at The Bardo Open 2023 for another great event!
At The Bardo Foundation, we believe that every child deserves access to technology and the endless opportunities it brings. That's why we are thrilled to announce our recent donation of iPads to the pediatric osteosarcoma patients at Oslo University Hospital, Radiumhospitalet.
Osteosarcoma is a type of bone cancer that affects children and adolescents. Treatment for this condition often involves lengthy hospital stays and intense pain management. During these difficult times, the distraction and entertainment provided by an iPad can be a valuable tool in helping patients pass the time and maintain their spirits.
Unfortunately, not all children have access to this type of technology, which is why we saw it as our duty to step in and help. The Bardo Foundation is dedicated to improving the lives of children and families affected by cancer, and we believe that this donation will make a real difference in the lives of these pediatric patients.
We are proud to support the amazing work being done by the doctors and nurses at Oslo University Hospital, Radiumhospitalet. They provide exceptional care to these young patients and their families, and we are honored to play a small part in supporting their efforts.
As a foundation, we are committed to making a positive impact in the lives of children and families affected by cancer. We believe that every child deserves access to technology and the joy it can bring, and we will continue to find ways to support those in need.
The Bardo Foundation is proud to have partnered with Barnekreftforeningen, Dr. Anja Lee from Oslo University Hospital, and Dr. Justin Baker, MD from St. Jude Children’s Research Hospital in a recent conference to bring awareness to the importance of pediatric palliative care.
Palliative care is a specialized area of medicine that focuses on providing relief from the symptoms, pain, and stress of serious illness. It aims to improve quality of life for both the patient and their family. While palliative care is often associated with end-of-life care, it can and should be provided at any stage of a serious illness and to people of all ages, including children.
Unfortunately, access to pediatric palliative care remains a challenge in many parts of the world. This is why it is crucial to bring attention to this issue and to educate healthcare professionals, families, and communities about the benefits of pediatric palliative care.
The conference was a great success and helped to raise awareness of the importance of pediatric palliative care. We hope that this will lead to more resources being dedicated to the development and improvement of pediatric palliative care services and that more children and families will have access to the support they need during their most difficult times.
At The Bardo Foundation, we believe that every child deserves access to high-quality healthcare, including palliative care. We will continue to work with our partners to bring attention to this critical issue and to support the development of pediatric palliative care services.
The Bardo Foundation is proud to announce our partnership with the Myrovlitis Trust in funding a very promising childhood cancer research project.
This research, led by Professor Nancy DeMore of the Medical University of South Carolina, focuses on the development of a combination therapy for metastatic osteosarcoma. The therapy involves the use of a humanized monoclonal antibody, which targets and destroys the cancer cells in the body. This new treatment is designed to work in combination with existing chemotherapy drugs, offering a more effective and efficient way to treat childhood cancer.
We believe that investing in medical research is crucial in the fight against childhood cancer. That is why we are honored to support Professor DeMore and her team in their efforts to find a cure. Their work has the potential to greatly improve the treatment and cure of childhood cancer, offering hope and a brighter future for children and their families.
At The Bardo Foundation, we are committed to making a positive difference in the lives of those affected by childhood cancer. Our partnership with the Myrovlitis Trust and support of this research project is just one example of our commitment to finding a cure for this devastating illness.
We are confident that Professor DeMore and her team will make a significant impact in the fight against childhood cancer and we are proud to support their efforts. We hope that the results of this research will lead to new and improved treatments for children with metastatic osteosarcoma, offering them a brighter future and a better chance at recovery.
At The Bardo Foundation, we believe in making a difference in the lives of those affected by serious illnesses. That's why we are proud to have contributed $5,000 towards MIB FACTOR 2022, a conference that gathers leading osteosarcoma researchers, clinicians, and patients to advance treatments and improve outcomes for those affected by this disease.
Osteosarcoma is a type of bone cancer that affects children and young adults. It requires a multi-disciplinary approach to treatment and a collaborative effort from the medical community to find better ways to fight the disease. This is where MIB FACTOR 2022 comes in, bringing together the best minds in the field to share knowledge and explore new possibilities.
Our contribution to MIB FACTOR 2022 demonstrates The Bardo Foundation's commitment to finding a cure for osteosarcoma. By supporting events like this, we aim to bring together the medical community to work towards a common goal and make a real impact in the lives of patients and their families.
At the conference, attendees had the opportunity to hear from leading experts in the field, including doctors, researchers, and patients. They discussed the latest developments in osteosarcoma research and explored new treatments and therapies to improve patient outcomes.
We are honored to have supported MIB FACTOR 2022 and to have played a small part in advancing the field of osteosarcoma research. We hope that our contribution will inspire others to support events like this and continue the important work of finding a cure for osteosarcoma.